Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have been given a consensus rating of “Moderate Buy” by the seven research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $40.14.

A number of research analysts have commented on SGRY shares. Macquarie started coverage on Surgery Partners in a research note on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective on the stock. Citigroup reduced their price objective on Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research note on Tuesday, July 9th. Finally, Benchmark reiterated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Wednesday, May 1st.

Surgery Partners Price Performance

Shares of Surgery Partners stock opened at $28.34 on Wednesday. The business’s fifty day moving average price is $25.49 and its 200 day moving average price is $28.10. The stock has a market capitalization of $3.60 billion, a P/E ratio of 32.77, a PEG ratio of 2.14 and a beta of 2.78. Surgery Partners has a twelve month low of $22.05 and a twelve month high of $40.31. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 0.92.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $717.40 million for the quarter, compared to analysts’ expectations of $707.66 million. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. As a group, research analysts anticipate that Surgery Partners will post 0.88 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Danielle Burkhalter sold 6,000 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total value of $158,340.00. Following the completion of the sale, the insider now directly owns 30,354 shares of the company’s stock, valued at $801,042.06. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.30% of the company’s stock.

Institutional Trading of Surgery Partners

Hedge funds and other institutional investors have recently bought and sold shares of the company. Strs Ohio bought a new stake in Surgery Partners in the fourth quarter valued at about $51,000. DekaBank Deutsche Girozentrale increased its holdings in Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares during the last quarter. Mesirow Institutional Investment Management Inc. increased its holdings in Surgery Partners by 12.4% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock valued at $108,000 after buying an additional 373 shares during the last quarter. Headlands Technologies LLC bought a new stake in Surgery Partners in the fourth quarter valued at about $145,000. Finally, EntryPoint Capital LLC increased its holdings in Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after buying an additional 4,607 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.